PhorMed

Utilizing gene therapy to target cancer and mutated cells

Print
Claim My Business
Security Type
Common Stock
Categories
Technology, Healthcare & Medical
Min Investment
$500
Location
Century City, CA
Offering Date
December 05, 2019
Expected Close Date
April 30, 2025
Target Raise
$50.00K-$5.00M
No. Investors
150
Security Price
$1
Deal Notes

Security Name: Common Stock

$1.00 per share

Valuation
$51,600,000
Website
phormed.com
Number of Employees
4
Cash
$303
Revenue
$0
Short Term Debt
$1,392,000
Cost of Goods
$0
Long Term Debt
$8,493
Net Income
$-750,289

Company Description

PhorMed is a biopharmaceutical company leading the charge in the field of genomic medicine. We utilize gene therapy to target cancer and mutated cells, allowing the body to begin healing itself, and give new hope to patients suffering from diseases like AML, Hodgkin’s Lymphoma and Parkinson’s, among others.

Perks

Invest >$500, you will receive 5% bonus shares & access to our Investor Club which allows you to vote on drug names, receive special investor updates, and attend Q&A sessions
If you invest >$1,500, you will receive 10% bonus shares & access to our Investor Club.
If you invest >$5,000, you will receive 15% bonus shares & access to our Investor Club.
If you invest >$10,000, you will receive 20% bonus shares, an in-person meeting with the leadership team**, and access to our Investor Club.
*Investors cannot qualify for both bonuses in any single investment. If an investor qualifies for two bonuses the higher of the two bonuses will be applied. All perks occur after the offering is completed.
**Travel Not Included

Key Deal Facts

Current first-line treatment options have severe side-effects and can be toxic
Exciting technology with the potential to treat multiple diseases means expanding opportunities for new markets and the potential for growth
The potential market is $8B+ per year

Use of Proceeds

Research & Development, Marketing, Company Employment, StartEngine Platform Fees

Management Team / Advisory Board Bios

McCoy Moretz M.D.
CEO/Treasurer/Secretary/CMO/Director; Dr. Moretz's primary job is at PhorMed but will continue being surgeon at his own practice, F.A.C.E. of Beverly Hills; Work at PhorMed entails spokes person for all speaking engagements, symposiums and conferences, manage all corporate and clincial directives, assist in protocol design, maintain clincal site communications, assist in expanding clinical sites, and manage all medical related work; 25 hrs/week and will increase as needed.

Prof. Richard L. Chang
Inventor and Scientific Affairs; Writes and publishes new findings, manages all scientific related work, assists writing and appoves all protocol designs, continues the work to better understand the mechanisms of action, and creates all 'methods' for analytical, manufacturing and clinical operations; full time with PhorMed

Isis Luna
Operations Director; Manages all internal operations, human resources, keeps all records and maintains all meeting minutes and filings; full time with PhorMed

Steven J. Davis
Legal Councel; Mr. Davis has his own law practice and primary job at SD Law Group APC; Work at PhorMed entails managing and maintaining all legal, filings, compliance and regulatory matters; 5 hours/week or as needed

Joseph Huffman
Financial Director; Mr. Huffman has his own CPA firm and primary job at Huffman & Huffman, LLC; Work at PhorMed entails maintaining accounting books, A/P, A/R, payroll, taxes, creates financial statements, and files all tax returns; 10hrs/week or as needed

Deal Notes

Security Name: Common Stock

$1.00 per share

Amount Raised : $177,393
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments